Your face might be revealing a hidden vitamin D deficiency through subtle changes like persistent dark circles and ...
Submissions are supported by data from the Phase 3 Viti-Up clinical studies demonstrating upadacitinib achieved the co-primary endpoints of at least a 50% improvement ...
writes on health, immigration, motherhood, and identity. Once a hater of makeup, she and her three children now use eyeshadow ...
The FDA has granted Breakthrough Therapy designation for litifilimab for the treatment of cutaneous lupus erythematosus, a chronic autoimmune skin disease.
Subcutaneous anifrolumab is superior to placebo in multiple systemic lupus erythematosus disease activity measures at 52 weeks, according to data published in Arthritis & Rheumatology.“As a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results